Mibefradil Alleviates High-Glucose–Induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/MTOR-Mediated Autophagy
LG Zhao, PL Li, Y Dai, JL Deng, MY Shan… - Journal of …, 2020 - journals.lww.com
Cardiac hypertrophy causes heart failure and is associated with hyperglycemia in patients
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy.
LG Zhao, PL Li, Y Dai, JL Deng, MY Shan… - Journal of …, 2020 - europepmc.org
Cardiac hypertrophy causes heart failure and is associated with hyperglycemia in patients
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
Mibefradil Alleviates High-Glucose-induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy
LG Zhao, PL Li, Y Dai, JL Deng… - Journal of …, 2020 - pubmed.ncbi.nlm.nih.gov
Cardiac hypertrophy causes heart failure and is associated with hyperglycemia in patients
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
Mibefradil Alleviates High-Glucose–induced Cardiac Hypertrophy by Inhibiting PI3K/Akt/mTOR-mediated Autophagy
LG Zhao, PL Li, Y Dai, JL Deng, MY Shan… - Journal of …, 2020 - journals.lww.com
Cardiac hypertrophy causes heart failure and is associated with hyperglycemia in patients
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …
with diabetes mellitus. Mibefradil, which acts as a T-type calcium channel blocker, exerts …